Laboratorija 1 - Company finances
|
EUR
|
2019
From: 2019-02-27
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 2,600 | 90,040 | 125,184 | 311,593 | 290,733 | 292,051 | 705,901 |
| Profit before tax | - | - | -33,797 | - | - | 3,426 | 93,771 |
| Net profit | 25 | 26,224 | -33,797 | 9,425 | 32,613 | 2,537 | 85,931 |
| Equity | 2,525 | 129,037 | 129,040 | 138,465 | 176,536 | 179,073 | 265,004 |
| Liabilities | 13,606 | 27,804 | 71,199 | 135,382 | 140,440 | 276,296 | 328,309 |
| Non-current assets | 13,423 | 23,000 | 135,109 | 175,724 | 204,545 | 402,716 | 481,732 |
| Current assets | 2,708 | 133,549 | 63,874 | 96,419 | 102,837 | 49,461 | 109,040 |
| Total assets | 16,131 | 156,549 | 198,983 | 272,143 | 307,382 | 452,177 | 590,772 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 95,435 | 77,842 | 150,092 |
| Social insurance contributions | - | - | - | - | 45,511 | 61,241 | 96,891 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | +3363.1% | +39.0% | +148.9% | -6.7% | +0.5% | +141.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.2% | 16.8% | -17.0% | 3.5% | 10.6% | 0.6% | 14.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 1.0% | 20.3% | -26.2% | 6.8% | 18.5% | 1.4% | 32.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.0% | 29.1% | -27.0% | 3.0% | 11.2% | 0.9% | 12.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | -27.0% | - | - | 1.2% | 13.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 5.4 | 0.2 | 0.6 | 1.0 | 0.8 | 1.5 | 1.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 1,300 | 17,427 | 8,785 | 18,151 | 26,837 | 21,633 | 46,037 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Laboratorija 1 - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-05-16 | 2025-06-02 | 93.20 |
| 2023-05-16 | 2023-05-30 | 1.15 |
| 2023-05-02 | 2023-05-07 | 1.15 |
| 2023-04-26 | 2023-04-28 | 1.15 |
| 2022-11-21 | 2022-11-27 | 9.46 |
| 2022-11-17 | 2022-11-18 | 9.46 |
| 2022-09-16 | 2022-09-19 | 6306.95 |
Laboratorija 1 - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-06-03 | 2026-06-05 | 4.44 |
| 2026-06-02 | 2026-06-02 | 4.41 |
| 2026-06-01 | 2026-06-01 | 2129.1 |
| 2026-05-31 | 2026-05-31 | 2112.27 |
| 2026-05-30 | 2026-05-30 | 2060.16 |
| 2025-09-12 | 2025-09-17 | 113.09 |
| 2025-09-11 | 2025-09-11 | 9410.69 |
| 2025-06-19 | 2025-06-26 | 1.23 |
| 2025-06-02 | 2025-06-02 | 1534.49 |
| 2025-05-31 | 2025-06-01 | 1531.97 |
| 2025-05-29 | 2025-05-30 | 1515.51 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Laboratorija 1, UAB (code 305049189) is a Private Limited Liability Company active in research and experimental development on other natural sciences and engineering. In 2025, the company generated revenue of EUR 705.9K and net profit of EUR 85.9K, with a profit margin of 12.2%. Revenue increased sharply by 141.7% year on year and by 142.8% over two years. Profitability also strengthened after a weak 2024, when revenue was EUR 292.1K and net profit only EUR 2.5K, compared with EUR 290.7K of revenue and EUR 32.6K of net profit in 2023. The balance sheet expanded to EUR 590.8K in 2025, supported by equity of EUR 265.0K and liabilities of EUR 328.3K, giving an equity ratio of 44.9% and a debt-to-equity ratio of 1.24. Long-term assets were EUR 481.7K and short-term assets EUR 109.0K. Efficiency indicators were solid, with ROE at 32.4%, ROA at 14.6%, and asset turnover at 1.19x. Revenue per employee was EUR 47.1K, and profit per employee EUR 5.7K.